Answer
After reconstitution, clear or slightly opalescent Fibrogammin (factor XIII) solution is warmed to room or body temperature and slowly injected or infused intravenously through the supplied separate line at a comfortable rate not exceeding approximately 4 ml/minute, with monitoring for immediate reactions and slowing or stopping administration if required.
Sources for this answer
- Fibrogammin 250 / 1250 IUCSL Behring UK Limited · emc · SmPC §4.2 Posology and method of administration · Version 20Document updated
Sources checked